Previous close | 358.71 |
Open | 359.20 |
Bid | 358.01 x 900 |
Ask | 358.25 x 800 |
Day's range | 355.68 - 359.50 |
52-week range | 249.98 - 361.41 |
Volume | |
Avg. volume | 1,325,598 |
Market cap | 136.085B |
Beta (5Y monthly) | 0.90 |
PE ratio (TTM) | 43.38 |
EPS (TTM) | 8.25 |
Earnings date | 29 Apr 2024 - 03 May 2024 |
Forward dividend & yield | 3.20 (0.89%) |
Ex-dividend date | 27 Mar 2024 |
1y target est | 362.37 |
Walgreens Boots' (WBA) comparable pharmacy sales in the fiscal second quarter benefited from higher branded drug inflation and strong execution in pharmacy services.
Investors are optimistic about STERIS (STE) on strong Healthcare business performance and raised 2024 guidance.
Lantheus' (LNTH) focus on pipeline development raises optimism about the stock.